AHA/ASA Journals2h
Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction
BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) ...
AHA/ASA Journals4d
Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association
Despite insufficient evidence to support direct-to-consumer genetic testing in routine clinical care, cardiovascular ...
AHA/ASA Journals4d
Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote Heart Failure With Preserved Ejection Fraction
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
ahajournals.org6d
Sex Differences in Peripheral Vascular Disease: A Scientific Statement From the American Heart Association
Sex differences in the risk factors, diagnosis, treatment, and outcomes of patients with cardiovascular disease have been well described; however, the bulk of the literature has focused on heart ...
ahajournals.org4d
Harnessing Electronic Health Records and Artificial Intelligence for Enhanced Cardiovascular Risk Prediction: A Comprehensive Review
Electronic health records (EHR) have revolutionized cardiovascular disease (CVD) research by enabling comprehensive, large‐scale, and dynamic data collection. Integrating EHR data with advanced ...
ahajournals.org6d
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
Department of Medicine, Boston Medical Center, MA (S.E.C., A.V.). Department of Medicine, Section of Nephrology, Boston University Chobanian & Avedisian School of ...